Does ETOPOSIDE Cause Recurrent cancer? 53 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Recurrent cancer have been filed in association with ETOPOSIDE (Avopef). This represents 0.1% of all adverse event reports for ETOPOSIDE.
53
Reports of Recurrent cancer with ETOPOSIDE
0.1%
of all ETOPOSIDE reports
22
Deaths
12
Hospitalizations
How Dangerous Is Recurrent cancer From ETOPOSIDE?
Of the 53 reports, 22 (41.5%) resulted in death, 12 (22.6%) required hospitalization, and 2 (3.8%) were considered life-threatening.
Is Recurrent cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETOPOSIDE. However, 53 reports have been filed with the FAERS database.
What Other Side Effects Does ETOPOSIDE Cause?
Off label use (6,495)
Febrile neutropenia (5,966)
Disease progression (3,776)
Drug ineffective (3,687)
Neutropenia (3,641)
Thrombocytopenia (3,085)
Product use in unapproved indication (2,774)
Anaemia (2,586)
Pyrexia (2,453)
Sepsis (2,211)
What Other Drugs Cause Recurrent cancer?
NIRAPARIB (776)
IMATINIB (237)
CYCLOPHOSPHAMIDE (143)
TRASTUZUMAB (121)
CAPECITABINE (108)
PEMBROLIZUMAB (107)
RITUXIMAB (99)
DOXORUBICIN (97)
OCTREOTIDE (95)
METHOTREXATE (81)
Which ETOPOSIDE Alternatives Have Lower Recurrent cancer Risk?
ETOPOSIDE vs ETORICOXIB
ETOPOSIDE vs ETRASIMOD ARGININE
ETOPOSIDE vs ETRAVIRINE
ETOPOSIDE vs EUCALYPTOL\MENTHOL\METHYL SALICYLATE\THYMOL
ETOPOSIDE vs EVEROLIMUS